marker robustly expressed in myelinating glia in the
mutations isolated in this screen, st14 and st48, have oligonucleotide (MO) designed against erbb3 reduced mbp expression in the PNS ( Figure 1F ; 100% affected, related but distinct phenotypes in PNS myelination. We mapped both mutations to the same region of linkage n = 65), whereas a mismatch control MO had no effect ( Figure 1E ; 100% wild-type, n = 12). On the basis of group (LG) 23, near the marker Z6142 and the gene wnt1 ( Figure 1A ). Despite the differences in mutant phemapping, identification of lesions in two alleles, and MO phenocopy experiments, we conclude that erbb3 notype (see below), mapping and complementation data ( Figures 1C and 1D ) indicated that st14 and st48 is the gene disrupted by st14 and st48. are allelic mutations.
Comparative synteny analysis suggested a zebrafish
Molecular Analysis of Mutations in erbb2
The screen for mutations disrupting mbp expression homolog of the neuregulin receptor erbb3 as a candidate for the gene disrupted by st14 and st48-no zealso yielded st50, and we found st61 in a screen for mutants with disrupted axons in the PNS (M.G.V. and brafish erbb3 gene had been described, but the erbb3 gene is located near wnt1 in the human and pufferfish W.S.T., unpublished data). Both mutants have similar phenotypes, characterized by strong reduction of mbp genomes. We identified a zebrafish erbb3 homolog in the Sanger Institute genomic sequence database and expression and defasciculation of axons in the PNS ( Figures 2D, 3S , 3U, 3X, and 3Z). The st61 and st50 mapped it to LG23 near wnt1-the same location as the st14 and st48 mutations ( Figure 1A) . mutations fail to complement ( Figure 2D ), and mapping showed that both mutations reside on LG12, near a zeThe predicted zebrafish ErbB3 protein is 54% identical to the human ErbB3 protein and has characteristic brafish homolog of erbb2 (Figure 2A ), which encodes a protein that forms a heteromeric neuregulin receptor ErbB3 sequence features, including a kinase homology domain that contains an asparagine residue in a posiwith ErbB3 [20]. The zebrafish gene is widely expressed in 20-24 hpf embryos (data not shown) and encodes a tion normally occupied by aspartic acid in kinases ( Figure 1B) . As in mouse, the zebrafish erbb3 gene is predicted protein that is 54% identical to human ErbB2 ( Figure 2B ). Injection of antisense morpholino oligonuexpressed in premigratory neural crest ( Figure 1G ), migrating neural crest ( Figure 1H) , and in putative glia ascleotides showed that erbb2 is essential for mbp expression in the larval PNS: all individuals (n = 32) insociated with cranial ganglia and peripheral nerves ( Figures 1I-1K) .
jected with the erbb2 MO had reduced or absent mbp expression in the posterior lateral line nerve at 5 dpf Sequence analysis of erbb3 in the st48 mutant identified a premature stop codon that truncates the pre-( Figure 2F ), whereas individuals injected with a mismatch control MO had normal mbp expression (Figure dicted protein in the extracellular domain ( Figure 1B ). All st48 mutants analyzed were homozygous for this 2E; n = 32). Sequence analysis of the erbb2 gene identified a prelesion (n = 82). Sequence analysis of st14 mutants identified a G to A mutation that changed a highly conmature stop codon in st61 mutants, which truncates the ErbB2 protein upstream of the transmembrane reserved Cys to a Tyr in the extracellular domain ( Figure  1B ). All st14 mutants analyzed were homozygous for gion ( Figure 2B ). All mutants sequenced were homozygous for this lesion (n = 10). Analysis of erbb2 sethis lesion (n = 29). Injection of an antisense morpholino (Figures 3N, 3S, and 3X) , and the axons of the PLL (e.g., see Figure 3B ). nerve are defasciculated ( Figures 3P, 3U, and 3Z ). MuTo determine if erbb3 function is essential for tants for both genes have normal morphology at 4 dpf, Schwann cell migration in the PLLn, we monitored indicating that the defects in mbp expression and axo- AG1478 from 10 hpf to 96 hpf had almost no Mbp expression in the PNS, whereas controls had robust Mbp expression at this stage ( Figures 6A and 6B ). Mbp exSchwann Cells Can Comigrate with Axons pression in treated larvae was very similar to erbb2 and in the Absence of Proliferation erbb3 mutants, consistent with previous data that From the foregoing analyses, it is possible that a defect AG1478 is a specific ErbB inhibitor. In addition, treated in proliferation could create a dearth of Schwann cells larvae were not morphologically distinguishable from that severely limits the extent of migration along the the controls, and we observed no nonspecific effects PLLn. To determine whether proliferation is required for of AG1478 treatment at a 4 M concentration (data not Schwann cell migration, we analyzed foxd3::gfp emshown). Lower doses of the drug reduced Mbp expresbryos in which cell division was blocked. To inhibit DNA sion along the anterior lateral line nerve but left some replication, we treated embryos with hydroxyurea and expression in the posterior lateral line nerve intact (Figaphidicolin beginning at 15 hpf. Analysis of the phosure 6C), a phenotype similar to the weaker erbb3 allele, pho-histone H3 antibody, which labels cells at the erbb3 st14 . We also found that erbb3 st48 /+ heterozygous G2-M transition, showed that this treatment greatly reembryos were more sensitive to AG1478 than wildduced the number of mitotic cells between 18 and 28 type, providing further support that AG1478 specifically hpf, which covers the period before and during which interferes with ErbB signaling. Six of ten erbb3 -7K and Movie S3). In three difImportantly, the migration of growing axons was normal in these AG1478-treated specimens, demonstrating ferent specimens analyzed, the majority of these GFP- To test the prediction that ErbB signaling is required for the onset of myelination in postmigratory Schwann foxd3:gfp-labeled cells along the PLLn incorporated BrdU (Figures 8A and 8C) . In contrast, the PLLn of cells, we examined Mbp protein expression in foxd3:: gfp larvae incubated in AG1478 from either 2 or 3 dpf AG1478-treated specimens (n = 9) contained only 29.6 cells labeled with GFP and BrdU (Figures 8B and 8C) . TTT-3# and 5#-AGCTTTAGGTGTACTCCTTGT-3#) and inserted into the pCRII vector (Invitrogen) to generate expression constructs.
Figure 7. ErbB Signaling Is Required Continuously for Comigration of Schwann Cells and Axons

All panels show foxd3::gfp transgenic embryos treated with AG1478 for the indicated period (C-K) or untreated controls (A and B). (A-H) Confocal images of GFP (green) and acetylated tubulin (red) at 48 hpf. The same cells are marked (arrowheads) in (A), (B), (C), (D), (G), and (H); an arrow marks approximately the same position in the embryos shown in (E) and (F). Addition of AG1478 allows axons, but not Schwann cells, to continue their directed migration. Schwann cells can resume migration after removal of AG1478 (compare [G] and [H] to [E] and [F]). (I-K)
Conclusions
The erbb2 ORF was resequenced and subcloned into the pCS2+
Our analysis has established multiple roles for ErbB 
BrdU Labeling
Embryos were pulse labeled with 2 mg/ml BrdU in 15% DMSO on Genetic Mapping Mutations were mapped by bulked segregant analysis with SSLPs ice for 20 min. After incubation with BrdU, embryos were returned to embryo medium at 28.5°C for at least 15 min to recover. by standard methods [30] . Initial mapping indicated that SSLP
